Tofacitinib reduces medical costs and risk of job loss in RA
Tofacitinib reduces medical costs and the risk of job loss in patients with rheumatoid arthritis (RA), according to findings of a Pfizer-sponsored post hoc analysis published in Rheumatology..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2017 |
|---|---|
| Enthalten in: |
PharmacoEconomics & outcomes news - (2017), 778, Seite 32 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| BKL: | |
|---|---|
| Themen: |
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1996366785 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1996366785 | ||
| 003 | DE-627 | ||
| 005 | 20230511181117.0 | ||
| 007 | tu | ||
| 008 | 170901s2017 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a PQ20170901 |
| 035 | |a (DE-627)OLC1996366785 | ||
| 035 | |a (DE-599)GBVOLC1996366785 | ||
| 035 | |a (PRQ)proquest_journals_19258607480 | ||
| 035 | |a (KEY)0248955420170000000077800032tofacitinibreducesmedicalcostsandriskofjoblossinra | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 070 |a 610 |q DE-600 |
| 084 | |a PHARM |2 fid | ||
| 084 | |a 44.40 |2 bkl | ||
| 245 | 1 | 0 | |a Tofacitinib reduces medical costs and risk of job loss in RA |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a Tofacitinib reduces medical costs and the risk of job loss in patients with rheumatoid arthritis (RA), according to findings of a Pfizer-sponsored post hoc analysis published in Rheumatology. | ||
| 650 | 4 | |a Expenditures | |
| 650 | 4 | |a Rheumatoid arthritis | |
| 650 | 4 | |a Rheumatology | |
| 650 | 4 | |a FDA approval | |
| 773 | 0 | 8 | |i Enthalten in |t PharmacoEconomics & outcomes news |d Auckland : Wolters Kluwer Health Adis, 1996 |g (2017), 778, Seite 32 |w (DE-627)193388901 |w (DE-600)1308910-9 |w (DE-576)435516213 |x 1173-5503 |7 nnns |
| 773 | 1 | 8 | |g year:2017 |g number:778 |g pages:32 |
| 856 | 4 | 2 | |u https://search.proquest.com/docview/1925860748 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 936 | b | k | |a 44.40 |q AVZ |
| 951 | |a AR | ||
| 952 | |j 2017 |e 778 |h 32 | ||